Gorbalenya, A. E. et al. The species extreme acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536–544 (2020).
Zhou, P. et al. A pneumonia outbreak related to a brand new coronavirus of possible bat origin. Nature 579, 270–273 (2020).
Zhu, N. et al. A novel coronavirus from sufferers with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).
Coronavirus (COVID-19) Dashboard. WHO https://covid19.who.int/ (2022).
Telenti, A., Hodcroft, E. B. & Robertson, D. L. The evolution and biology of SARS-CoV-2 variants. Chilly Spring Harb. Persp. Med. 12, a041390 (2022).
Harvey, W. T. et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 19, 409–424 (2021).
Grant, R. et al. When to replace COVID-19 vaccine composition. Nat. Med. 29, 776–780 (2023).
Jungreis, I., Sealfon, R. & Kellis, M. SARS-CoV-2 gene content material and COVID-19 mutation affect by evaluating 44 Sarbecovirus genomes. Nat. Commun. 12, 2642 (2021).
Jungreis, I. et al. Conflicting and ambiguous names of overlapping ORFs within the SARS-CoV-2 genome: a homology-based decision. Virology 558, 145–151 (2021).
Finkel, Y. et al. The coding capability of SARS-CoV-2. Nature 589, 125–130 (2020).
Gordon, D. E. et al. A SARS-CoV-2 protein interplay map reveals targets for drug repurposing. Nature 583, 459–468 (2020).
Kim, D. et al. The structure of SARS-CoV-2 transcriptome. Cell 181, 914–921.e10 (2020).
Huston, N. C. et al. Complete in vivo secondary construction of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms. Mol. Cell 81, 584–598.e5 (2021).
Lan, T. C. T. et al. Secondary structural ensembles of the SARS-CoV-2 RNA genome in contaminated cells. Nat. Commun. 13, 1128 (2022).
Ziv, O. et al. The short- and long-range RNA–RNA interactome of SARS-CoV-2. Mol. Cell 80, 1067–1077.e5 (2020).
Madhugiri, R., Fricke, M., Marz, M. & Ziebuhr, J. Coronavirus cis-acting RNA components. Adv. Virus Res. 96, 127–163 (2016).
Tidu, A. et al. The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation. RNA 27, 253–264 (2021). This publication demonstrated that SARS-CoV-2 depends on stem loop 1 within the 5′ UTR to evade the nsp1-induced translational shutoff of its personal genes.
Bujanic, L. et al. The important thing options of SARS-CoV-2 chief and NSP1 required for viral escape of NSP1-mediated repression. RNA 28, 766–779 (2022).
Iserman, C. et al. Genomic RNA components drive part separation of the SARS-CoV-2 nucleocapsid. Mol. Cell 80, 1078–1091.e6 (2020).
Bhatt, P. R. et al. Structural foundation of ribosomal frameshifting throughout translation of the SARS-CoV-2 RNA genome. Science 372, 1306–1313 (2021). In-depth structural and biochemical evaluation into the mechanism of the programmed ribosomal frameshift for SARS-CoV-2.
Solar, L. et al. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins weak to repurposed medication. Cell 184, 1865–1883.e20 (2021).
Jackson, C. B., Farzan, M., Chen, B. & Choe, H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23, 3–20 (2021). Complete evaluation on SARS-CoV-2 entry mechanism.
Hoffmann, M., Kleine-Weber, H. & Pöhlmann, S. A multibasic cleavage web site within the spike protein of SARS-CoV-2 is crucial for an infection of human lung cells. Mol. Cell 78, 779–784.e5 (2020). This text highlights the presence of a multibasic S1/S2 cleavage web site within the SARS-CoV-2 spike protein that may be minimize by furin and is a prerequisite for viral entry into lung cells.
Hansen, J. et al. Research in humanized mice and convalescent people yield a SARS-CoV-2 antibody cocktail. Science 369, 1010–1014 (2020).
Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 in convalescent people. Nature 584, 437–442 (2020).
Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583, 290–295 (2020).
Yuan, M. et al. A extremely conserved cryptic epitope within the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science 368, 630–633 (2020).
Liu, L. et al. Potent neutralizing antibodies in opposition to a number of epitopes on SARS-CoV-2 spike. Nature 584, 450–456 (2020). This is among the first publications to report the receptor-binding area (RBD) and N-terminal area (NTD) epitopes as the 2 most important neutralization targets on the SARS-CoV-2 spike protein.
Chi, X. et al. A neutralizing human antibody binds to the N-terminal area of the spike protein of SARS-CoV-2. Science 369, 650–655 (2020).
Meng, B. et al. SARS-CoV-2 spike N-terminal area modulates TMPRSS2-dependent viral entry and fusogenicity. Cell Rep. 40, 111220 (2022). Right here, it was proven that the SARS-CoV-2 spike protein’s NTD can modulate S1/S2 cleavage and affect TMPRSS2 utilization and fusogenicity.
Hoffmann, M. et al. SARS-CoV-2 cell entry is dependent upon ACE2 and TMPRSS2 and is blocked by a clinically confirmed protease inhibitor. Cell 181, 271–280.e8 (2020). The primary publication to verify that, much like SARS-CoV, the processing of the SARS-CoV-2 spike protein is mediated by TMPRSS2.
Zhao, M. M. et al. Cathepsin L performs a key position in SARS-CoV-2 an infection in people and humanized mice and is a promising goal for brand new drug improvement. Sign. Transduct. Goal. Ther. 6, 134 (2021).
Ziegler, C. G. Ok. et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in particular cell subsets throughout tissues. Cell 181, 1016–1035.e19 (2020).
Su, M. C. et al. An atypical RNA pseudoknot stimulator and an upstream attenuation sign for −1 ribosomal frameshifting of SARS coronavirus. Nucleic Acids Res. 33, 4265–4275 (2005).
Zhang, Ok. et al. Cryo-EM and antisense focusing on of the 28-kDa frameshift stimulation factor from the SARS-CoV-2 RNA genome. Nat. Struct. Mol. Biol. 28, 747–754 (2021).
Brierley, I., Digard, P. & Inglis, S. C. Characterization of an environment friendly coronavirus ribosomal frameshifting sign: requirement for an RNA pseudoknot. Cell 57, 537–547 (1989).
Solar, Y. et al. Restriction of SARS-CoV-2 replication by focusing on programmed –1 ribosomal frameshifting. Proc. Natl Acad. Sci. USA 118, e2023051118 (2021).
Osipiuk, J. et al. Construction of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors. Nat. Commun. 12, 743 (2021).
Jin, Z. et al. Construction of Mprofessional from SARS-CoV-2 and discovery of its inhibitors. Nature 582, 289–293 (2020).
Ziebuhr, J., Snijder, E. J. & Gorbalenya, A. E. Virus-encoded proteinases and proteolytic processing within the Nidovirales. J. Gen. Virol. 81, 853–879 (2000).
Thoms, M. et al. Structural foundation for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science 369, 1249–1256 (2020). Thoms et al. (2020) and Schubert et al. (2020) elucidate the binding of SARS-CoV-2 nsp1 to the ribosome and trigger translational shutdown.
Schubert, Ok. et al. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation. Nat. Struct. Mol. Biol. 27, 959–966 (2020).
Fisher, T. et al. Parsing the position of NSP1 in SARS-CoV-2 an infection. Cell Rep. 39, 110954 (2022).
Snijder, E. J., Decroly, E. & Ziebuhr, J. The nonstructural proteins directing coronavirus RNA synthesis and processing. In Advances in Virus Analysis Vol. 96 (ed. Ziebuhr, J.) 59–126 (Educational Press, 2016).
Cortese, M. et al. Integrative imaging reveals SARS-CoV-2-induced reshaping of subcellular morphologies. Cell Host Microbe 28, 853–866.e5 (2020).
Snijder, E. J. et al. A unifying structural and purposeful mannequin of the coronavirus replication organelle: monitoring down RNA synthesis. PLoS Biol. 18, e3000715 (2020).
Wolff, G., Melia, C. E., Snijder, E. J. & Bárcena, M. Double-membrane vesicles as platforms for viral replication. Tendencies Microbiol. 28, 1022–1033 (2020).
Klein, S. et al. SARS-CoV-2 construction and replication characterised by in situ cryo-electron tomography. Nat. Commun. 11, 5885 (2020).
Ricciardi, S. et al. The position of NSP6 within the biogenesis of the SARS-CoV-2 replication organelle. Nature 606, 761–768 (2022).
Twu, W. I. et al. Contribution of autophagy equipment components to HCV and SARS-CoV-2 replication organelle formation. Cell Rep. 37, 110049 (2021).
Tabata, Ok. et al. Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation. Nat. Commun. 12, 7276 (2021).
Ji, M. et al. VMP1 and TMEM41B are important for DMV formation throughout β-coronavirus an infection. J. Cell Biol. 221, e202112081 (2022).
Wolff, G. et al. A molecular pore spans the double membrane of the coronavirus replication organelle. Science 369, 1395–1398 (2020).
Zimmermann, L. et al. SARS-CoV-2 nsp3 and nsp4 are minimal constituents of a pore spanning replication organelle. Nat. Commun. 14, 7894 (2023).
da Silva Gomes Dias, S. et al. Lipid droplets gas SARS-CoV-2 replication and manufacturing of inflammatory mediators. PLoS Pathog. 16, e1009127 (2020).
Malone, B., Urakova, N., Snijder, E. J. & Campbell, E. A. Buildings and capabilities of coronavirus replication–transcription complexes and their relevance for SARS-CoV-2 drug design. Nat. Rev. Mol. Cell Biol. 23, 21–39 (2021).
Gao, Y. et al. Construction of the RNA-dependent RNA polymerase from COVID-19 virus. Science 368, 779–782 (2020).
Wang, Q. et al. Structural foundation for RNA replication by the SARS-CoV-2 polymerase. Cell 23, 182–417.e13 (2020).
Hillen, H. S. et al. Construction of replicating SARS-CoV-2 polymerase. Nature 584, 154–156 (2020).
Mickolajczyk, Ok. J. et al. Pressure-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase. Biophys. J. 120, 1020–1030 (2021).
Chen, J. et al. Structural foundation for helicase-polymerase coupling within the SARS-CoV-2 replication–transcription advanced. Cell 182, 1560–1573.e13 (2020).
Yan, L. et al. Structure of a SARS-CoV-2 mini replication and transcription advanced. Nat. Commun. 11, 5874 (2020).
Malone, B. et al. Structural foundation for backtracking by the SARS-CoV-2 replication–transcription advanced. Proc. Natl Acad. Sci. USA 118, e2102516118 (2021).
Chen, J. et al. Ensemble cryo-EM reveals conformational states of the nsp13 helicase within the SARS-CoV-2 helicase replication–transcription advanced. Nat. Struct. Mol. Biol. 29, 250–260 (2022).
Nudler, E. RNA polymerase backtracking in gene regulation and genome instability. Cell 149, 1438–1445 (2012).
Shannon, A. et al. Fast incorporation of Favipiravir by the quick and permissive viral RNA polymerase advanced ends in SARS-CoV-2 deadly mutagenesis. Nat. Commun. 11, 4682 (2020).
Smith, E. C., Blanc, H., Vignuzzi, M. & Denison, M. R. Coronaviruses missing exoribonuclease exercise are inclined to deadly mutagenesis: proof for proofreading and potential therapeutics. PLoS Pathog. 9, e1003565 (2013).
Lin, S. et al. Crystal construction of SARS-CoV-2 nsp10 certain to nsp14–ExoN area reveals an exoribonuclease with each structural and purposeful integrity. Nucleic Acids Res. 49, 5382–5392 (2021).
Liu, C. et al. Structural foundation of mismatch recognition by a SARS-CoV-2 proofreading enzyme. Science 373, 1142–1146 (2021).
Yan, L. et al. Coupling of N7-methyltransferase and three′-5′ exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading. Cell 184, 3474–3485.e11 (2021).
Sawicki, S. G. & Sawicki, D. L. Coronaviruses use discontinuous extension for synthesis of subgenome-length adverse strands. In Advances in Experimental Medication and Biology Vol. 380 (eds Talbot, P. J. & Levy, G. A.) 499–506 (Springer, 1995).
Wang, D. et al. The SARS-CoV-2 subgenome panorama and its novel regulatory options. Mol. Cell 81, 2135–2147.e5 (2021).
Sola, I., Almazán, F., Zúñiga, S. & Enjuanes, L. Steady and discontinuous RNA synthesis in coronaviruses. Annu. Rev. Virol. 2, 265–288 (2015).
Zhang, Y. et al. In vivo construction and dynamics of the SARS-CoV-2 RNA genome. Nat. Commun. 12, 5695 (2021).
Mendez, A. S. et al. The N-terminal area of SARS-CoV-2 nsp1 performs key roles in suppression of mobile gene expression and preservation of viral gene expression. Cell Rep. 37, 109841 (2021).
Vora, S. M. et al. Focusing on stem-loop 1 of the SARS-CoV-2 50 UTR to suppress viral translation and Nsp1 evasion. Proc. Natl Acad. Sci. USA 119, e2117198119 (2022).
Finkel, Y. et al. SARS-CoV-2 makes use of a multipronged technique to impede host protein synthesis. Nature 594, 240–245 (2021).
Walker, A. P. et al. The SARS-CoV-2 RNA polymerase is a viral RNA capping enzyme. Nucleic Acids Res. 49, 13019–13030 (2021). These authors establish the nidovirus RdRP-associated nucleotidyltransferase (NiRAN) area of nsp12 as a capping enzyme concerned within the formation of the cap core construction.
Pan, R. et al. N7-methylation of the coronavirus RNA cap is required for maximal virulence by stopping innate immune recognition. mBio 13, e0366221 (2022).
Russ, A. et al. Nsp16 shields SARS–CoV-2 from environment friendly MDA5 sensing and IFIT1-mediated restriction. EMBO Rep. 23, e55648 (2022).
Decroly, E., Ferron, F., Lescar, J. & Canard, B. Standard and unconventional mechanisms for capping viral mRNA. Nat. Rev. Microbiol. 10, 51–65 (2012).
Kikkert, M. Innate immune evasion by human respiratory RNA viruses. J. Innate Immun. 12, 4–20 (2020).
Chen, Y. et al. Purposeful display screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc. Natl Acad. Sci. 106, 3484–3489 (2009).
Bouvet, M. et al. In vitro reconstitution of SARS-coronavirus mRNA cap methylation. PLoS Pathog. 6, e1000863 (2010).
Lehmann, Ok. C. et al. Discovery of a necessary nucleotidylating exercise related to a newly delineated conserved area within the RNA polymerase-containing protein of all nidoviruses. Nucleic Acids Res. 43, 8416–8434 (2015).
Slanina, H. et al. Coronavirus replication-transcription advanced: very important and selective NMPylation of a conserved web site in nsp9 by the NiRAN–RdRp subunit. Proc. Natl Acad. Sci. USA 118, e2022310118 (2021).
Yan, L. et al. Cryo-EM construction of an prolonged SARS-CoV-2 replication and transcription advanced reveals an intermediate state in cap synthesis. Cell 184, 184–193.e10 (2021).
Park, G. J. et al. The mechanism of RNA capping by SARS-CoV-2. Nature 609, 793–800 (2022). These authors present the RNAylation of nsp9 by NiRAN in vitro and therefore suggest an unconventional capping mechanism for SARS-CoV-2.
Yan, L. et al. A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors. Cell 185, 4347–4360.e17 (2022).
Ogino, T. & Inexperienced, T. J. RNA synthesis and capping by non-segmented adverse strand RNA viral polymerases: classes from a prototypic virus. Entrance. Microbiol. 10, 1490 (2019).
Wang, B., Svetlov, D. & Artsimovitch, I. NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN area. Nucleic Acids Res. 49, 8822–8835 (2021).
Cong, Y. et al. Nucleocapsid protein recruitment to replication–transcription complexes performs a vital position in coronaviral life cycle. J. Virol. 94, e01925–e02019 (2020).
Cubuk, J. et al. The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and part separates with RNA. Nat. Commun. 12, 1936 (2021).
Lu, S. et al. The SARS-CoV-2 nucleocapsid phosphoprotein kinds mutually unique condensates with RNA and the membrane-associated M protein. Nat. Commun. 12, 502 (2021).
Yao, H. et al. Molecular structure of the SARS-CoV-2 virus. Cell 183, 730–738.e13 (2020).
Bracquemond, D. & Muriaux, D. Betacoronavirus meeting: clues and views for elucidating SARS-CoV-2 particle formation and egress. mBio 12, e0237121 (2021).
Cascarina, S. M. & Ross, E. D. Section separation by the SARS-CoV-2 nucleocapsid protein: consensus and open questions. J. Biol. Chem. 298, 101677 (2022).
Boson, B. et al. The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, permitting meeting of virus-like particles. J. Biol. Chem. 296, 100111 (2021).
de Haan, C. A. M. & Rottier, P. J. M. Molecular interactions within the meeting of coronaviruses. Adv. Virus Res. 64, 165–230 (2005).
Mandala, V. S. et al. Construction and drug binding of the SARS-CoV-2 envelope protein transmembrane area in lipid bilayers. Nat. Struct. Mol. Biol. 27, 1202–1208 (2020).
Nieto-Torres, J. L. et al. Extreme acute respiratory syndrome coronavirus E protein transports calcium ions and prompts the NLRP3 inflammasome. Virology 485, 330–339 (2015).
Ghosh, S. et al. β-Coronaviruses use lysosomes for egress as an alternative of the biosynthetic secretory pathway. Cell 183, 1520–1535.e14 (2020). This paper first proposed and investigated the egress of SARS-CoV-2 and different betacoronaviruses by way of lysosomal trafficking.
Tancini, B. et al. Lysosomal exocytosis: the extracellular position of an intracellular organelle. Membranes 10, 406 (2020).
Pu, J. et al. BORC, a multisubunit advanced that regulates lysosome positioning. Dev. Cell 33, 176–188 (2015).
Chen, D. et al. ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress. Dev. Cell 56, 3250–3263.e5 (2021).
Minkoff, J. M. & tenOever, B. Innate immune evasion methods of SARS-CoV-2. Nat. Rev. Microbiol. 21, 178–194 (2023). Complete evaluation on SARS-CoV-2 innate immune evasion.
Gao, B. et al. Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures environment friendly virus replication. PLoS Pathog. 17, e1008690 (2021).
Banerjee, A. Ok. et al. SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell 183, 1325–1339.e21 (2020). They recognized the viral proteins concerned (nsp1, nap8, nsp9 and nsp16) in international inhibition of host mRNA splicing, protein translation and membrane protein trafficking.
Hayn, M. et al. Systematic purposeful evaluation of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities. Cell Rep. 35, 109126 (2021).
Lei, X. et al. Activation and evasion of kind I interferon responses by SARS-CoV-2. Nat. Commun. 11, 3812 (2020).
Li, J. Y. et al. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit kind I interferon signaling pathway. Virus Res. 286, 198074 (2020).
Shemesh, M. et al. SARS-CoV-2 suppresses IFNβ manufacturing mediated by NSP1, 5, 6, 15, ORF6 and ORF7b however doesn’t suppress the results of added interferon. PLoS Pathog. 17, e1009800 (2021).
Stukalov, A. et al. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature 594, 246–252 (2021).
Vazquez, C. et al. SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation by means of distinct mechanisms. PLoS One 16, e0253089 (2021).
Xia, H. et al. Evasion of kind I interferon by SARS-CoV-2. Cell Rep. 33, 108234 (2020). One of many first papers to report the interferon antagonism of SARS-CoV-2.
Yuen, C. Ok. et al. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 perform as potent interferon antagonists. Emerg. Microbes Infect. 9, 1418–1428 (2020).
Zheng, M. et al. TLR2 senses the SARS-CoV-2 envelope protein to provide inflammatory cytokines. Nat. Immunol. 22, 829–838 (2021).
Planès, R., Bert, J. B., Tairi, S., Benmohamed, L. & Bahraoui, E. SARS-CoV-2 envelope (E) protein binds and prompts TLR2 pathway: a novel molecular goal for COVID-19 interventions. Viruses 14, 999 (2022).
Moreno-Eutimio, M. A., López-Macías, C. & Pastelin-Palacios, R. Bioinformatic evaluation and identification of single-stranded RNA sequences acknowledged by TLR7/8 within the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes. Microbes Infect. 22, 226–229 (2020).
Choudhury, A. & Mukherjee, S. In silico research on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J. Med. Virol. 92, 2105–2113 (2020).
Bortolotti, D. et al. Tlr3 and tlr7 RNA sensor activation throughout SARS-CoV-2 an infection. Microorganisms 9, 1820 (2021).
Rebendenne, A. et al. SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to regulate replication in lung epithelial cells. J. Virol. 95, e02415–e02420 (2021).
Thorne, L. G. et al. SARS‐CoV‐2 sensing by RIG‐I and MDA5 hyperlinks epithelial an infection to macrophage irritation. EMBO J. 40, e107826 (2021).
Yang, D.-M., Geng, T.-T., Harrison, A. G. & Wang, P.-H. Differential roles of RIG-I like receptors in SARS-CoV-2 an infection. Milit. Med. Res. 8, 49 (2021).
Yin, X. et al. MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells. Cell Rep. 34, 108628 (2021).
Frazier, M. N. et al. Flipped over U: structural foundation for dsRNA cleavage by the SARS-CoV-2 endoribonuclease. Nucleic Acids Res. 50, 8290–8301 (2022).
Hackbart, M., Deng, X. & Baker, S. C. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors. Proc. Natl Acad. Sci. USA 117, 8094–8103 (2020).
Ancar, R. et al. Physiologic RNA targets and refined sequence specificity of coronavirus EndoU. RNA 26, 1976–1999 (2020).
Singh, Ok. Ok., Chaubey, G., Chen, J. Y. & Suravajhala, P. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am. J. Physiol. Cell Physiol. 319, C258–C267 (2020).
Schoggins, J. W. et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505, 691–695 (2014).
Solar, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP–AMP synthase is a cytosolic DNA sensor that prompts the sort I interferon pathway. Science 339, 786–791 (2013).
Rui, Y. et al. Distinctive and complementary suppression of cGAS-STING and RNA sensing — triggered innate immune responses by SARS-CoV-2 proteins. Sign. Transduct. Goal. Ther. 6, 123 (2021).
Humphries, F. et al. A diamidobenzimidazole STING agonist protects in opposition to SARS-CoV-2 an infection. Sci. Immunol. 6, eabi9002 (2021).
Li, M. et al. Pharmacological activation of STING blocks SARS-CoV-2 an infection. Sci. Immunol. 6, eabi9007 (2021).
Christgen, S. & Kanneganti, T.-D. Inflammasomes and the positive line between protection and illness. Curr. Opin. Immunol. 62, 39–44 (2020).
Kelley, N., Jeltema, D., Duan, Y. & He, Y. The NLRP3 inflammasome: an summary of mechanisms of activation and regulation. Int. J. Mol. Sci. 2019 20, 3328 (2019).
Campbell, G. R., To, R. Ok., Hanna, J. & Spector, S. A. SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages by means of a non-classical pathway. iScience 24, 102295 (2021).
Pan, P. et al. SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nat. Commun. 12, 4664 (2021).
Xu, H. et al. SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway. Virology 568, 13–22 (2022).
Rodrigues, T. S. et al. Inflammasomes are activated in response to SARS-cov-2 an infection and are related to COVID-19 severity in sufferers. J. Exp. Med. 218, e20201707 (2020).
Yalcinkaya, M. et al. Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein. Sci. Rep. 11, 24432 (2021).
Zhang, Y. et al. The ORF8 protein of SARS-CoV-2 mediates immune evasion by means of down-regulating MHC-Ι. Proc. Natl Acad. Sci. USA 118, e2024202118 (2021).
Arshad, N. et al. SARS-CoV-2 accent proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I floor expression. Proc. Natl Acad. Sci. USA 120, e2208525120 (2023).
Yoo, J. S. et al. SARS-CoV-2 inhibits induction of the MHC class I pathway by focusing on the STAT1-IRF1-NLRC5 axis. Nat. Commun. 12, 6602 (2021).
Menachery, V. D. et al. MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic panorama. Proc. Natl Acad. Sci. USA 115, E1012–E1021 (2018).
Kee, J. et al. SARS-CoV-2 disrupts host epigenetic regulation by way of histone mimicry. Nature 610, 381–388 (2022).
Kim, Y. M. & Shin, E. C. Sort I and III interferon responses in SARS-CoV-2 an infection. Exp. Mol. Med. 53, 750–760 (2021).
Liu, G. Q. et al. ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity. Nat. Microbiol. 6, 467–478 (2021).
Moustaqil, M. et al. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and significant modulators of inflammatory pathways (NLRP12 and TAB1): implications for illness presentation throughout species. Emerg. Microbes Infect. 10, 178–195 (2021).
Shin, D. et al. Papain-like protease regulates SARS-CoV-2 viral unfold and innate immunity. Nature 587, 657–662 (2020).
Zhang, S., Wang, J. & Cheng, G. Protease cleavage of RNF20 facilitates coronavirus replication by way of stabilization of SREBP1. Proc. Natl Acad. Sci. USA 118, e2107108118 (2021).
Miao, G. et al. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated meeting of the SNARE advanced required for autolysosome formation. Dev. Cell 56, 427–442.e5 (2021).
Sui, L. et al. SARS-CoV-2 membrane protein inhibits kind i interferon manufacturing by means of ubiquitin-mediated degradation of TBK1. Entrance. Immunol. 12, 662989 (2021).
Ren, Y. et al. The ORF3a protein of SARS-CoV-2 induces apoptosis in cells. Cell Mol. Immunol. 17, 881–883 (2020).
Zhang, Y. et al. The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes. Cell Discov. 7, 31 (2021).
Ashour, H. M., Elkhatib, W. F., Md. Rahman, M. & Elshabrawy, H. A. Insights into the current 2019 novel coronavirus (SARS-CoV-2) in mild of previous human coronavirus outbreaks. Pathogens 9, 186 (2020).
Shang, J. et al. Compositional range and evolutionary sample of coronavirus accent proteins. Temporary. Bioinform 22, 1267–1278 (2021).
Frieman, M. et al. Extreme acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 perform by sequestering nuclear import components on the tough endoplasmic reticulum/Golgi membrane. J. Virol. 81, 9812–9824 (2007).
Addetia, A. et al. SARS-CoV-2 ORF6 disrupts bidirectional nucleocytoplasmic transport by means of interactions with Rae1 and Nup98. mBio 12, e00065–e00121 (2021).
Kato, Ok. et al. Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore advanced. Biochem. Biophys. Res. Commun. 536, 59–66 (2021).
Kimura, I. et al. Sarbecovirus ORF6 proteins hamper induction of interferon signaling. Cell Rep. 34, 108916 (2021).
Miorin, L. et al. SARS-CoV-2 Orf6 hijacks Nup98 to dam STAT nuclear import and antagonize interferon signaling. Proc. Natl Acad. Sci. USA 117, 28344–28354 (2020).
Miyamoto, Y. et al. SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication. Commun. Biol. 5, 483 (2022).
Kehrer, T. et al. Affect of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis. Cell Host Microbe 31, 1668–1684.e12 (2023).
Zhang, Ok. et al. Nsp1 protein of SARS-CoV-2 disrupts the mRNA export equipment to inhibit host gene expression. Sci. Adv. 7, eabe7386 (2021).
Schubert, Ok. et al. Common options of Nsp1-mediated translational shutdown by coronaviruses. Mol. Cell 83, 3546–3557.e8 (2023).
Baggen, J., Vanstreels, E., Jansen, S. & Daelemans, D. Mobile host components for SARS-CoV-2 an infection. Nat. Microbiol. 6, 1219–1232 (2021).
Baggen, J. et al. Genome-wide CRISPR screening identifies TMEM106B as a proviral host issue for SARS-CoV-2. Nat. Genet. 53, 435–444 (2021).
Daniloski, Z. et al. Identification of required host components for SARS-CoV-2 an infection in human cells. Cell 184, 92–105.e16 (2021).
Wang, R. et al. Genetic screens establish host components for SARS-CoV-2 and customary chilly coronaviruses. Cell 184, 106–119.e14 (2021).
Schneider, W. M. et al. Genome-scale identification of SARS-CoV-2 and pan-coronavirus host issue networks. Cell 184, 120–132.e14 (2021).
Baggen, J. et al. TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry. Cell 186, 3427–3442.e22 (2023).
Rebendenne, A. et al. Bidirectional genome-wide CRISPR screens reveal host components regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs. Nat. Genet. 54, 1090–1102 (2022).
Biering, S. B. et al. Genome-wide bidirectional CRISPR screens establish mucins as host components modulating SARS-CoV-2 an infection. Nat. Genet. 54, 1078–1089 (2022).
Zhu, Y. et al. A genome-wide CRISPR display screen identifies host components that regulate SARS-CoV-2 entry. Nat. Commun. 12, 961 (2021).
Grodzki, M. et al. Genome-scale CRISPR screens establish host components that promote human coronavirus an infection. Genome Med. 14, 10 (2022).
Hoffmann, H. H. et al. Purposeful interrogation of a SARS-CoV-2 host protein interactome identifies distinctive and shared coronavirus host components. Cell Host Microbe 29, 267–280.e5 (2021).
Burkard, C. et al. Coronavirus cell entry happens by means of the endo-/lysosomal pathway in a proteolysis-dependent method. PLoS Pathog. 10, e1004502 (2014).
Schmidt, N. et al. The SARS-CoV-2 RNA–protein interactome in contaminated human cells. Nat. Microbiol. 6, 339–353 (2020). The authors present perception into mobile host components that immediately bind SARS-CoV-2 RNA in contaminated human cells and examine/clarify beforehand described capabilities.
Could, D. G. et al. A BioID-derived proximity interactome for SARS-CoV-2 proteins. Viruses 14, 611 (2022).
Ugalde, A. P. et al. Autophagy‐linked plasma and lysosomal membrane protein PLAC8 is a key host issue for SARS‐CoV‐2 entry into human cells. EMBO J. 41, e110727 (2022).
mac Kain, A. et al. Identification of DAXX as a restriction issue of SARS-CoV-2 by means of a CRISPR/Cas9 display screen. Nat. Commun. 13, 2442 (2022).
Brown, M. S. & Goldstein, J. L. A proteolytic pathway that controls the ldl cholesterol content material of membranes, cells, and blood. Proc. Natl Acad. Sci. USA 96, 11041–11048 (1999).
Kratzel, A. et al. A genome-wide CRISPR display screen identifies interactors of the autophagy pathway as conserved coronavirus targets. PLoS Biol. 19, e3001490 (2021).
Li, Y. E. et al. TMEM41B and VMP1 are scramblases and regulate the distribution of ldl cholesterol and phosphatidylserine. J. Cell Biol. 220, e202103105 (2021).
Lee, S. et al. The SARS-CoV-2 RNA interactome. Mol. Cell 81, 2838–2850.e6 (2021).
Labeau, A. et al. Characterization and purposeful interrogation of the SARS-CoV-2 RNA interactome. Cell Rep. 39, 110744 (2022).
Flynn, R. A. et al. Discovery and purposeful interrogation of SARS-CoV-2 RNA-host protein interactions. Cell 184, 2394–2411.e16 (2021).
Kamel, W. et al. International evaluation of protein–RNA interactions in SARS-CoV-2-infected cells reveals key regulators of an infection. Mol. Cell 81, 2851–2867.e7 (2021).
Chen, Z. et al. Interactomes of SARS-CoV-2 and human coronaviruses reveal host components doubtlessly affecting pathogenesis. EMBO J. 40, e107776 (2021).
Kruse, T. et al. Massive scale discovery of coronavirus-host issue protein interplay motifs reveals SARS-CoV-2 particular mechanisms and vulnerabilities. Nat. Commun. 12, 6761 (2021).
Zheng, Z.-Q., Wang, S.-Y., Xu, Z.-S., Fu, Y.-Z. & Wang, Y.-Y. SARS-CoV-2 nucleocapsid protein impairs stress granule formation to advertise viral replication. Cell Discov. 7, 38 (2021).
Kumar, A. et al. SARS-CoV-2 nonstructural protein 1 inhibits the interferon response by inflicting depletion of key host signaling components. J. Virol. 95, e0026621 (2021).
Xu, Z. et al. SARS-CoV-2 impairs interferon manufacturing by way of NSP2-induced repression of mRNA translation. Proc. Natl Acad. Sci. USA 119, e2204539119 (2022).
Alhammad, Y. M. O. et al. The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase. J. Virol. 95, e01969–e02020 (2021).
Liu, Y. et al. SARS-CoV-2 Nsp5 demonstrates two distinct mechanisms focusing on RIG-I and MAVS to evade the innate immune response. mBio 12, e0233521 (2021).
Zheng, Y. et al. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules. Sign. Transduct. Goal. Ther. 7, 22 (2022).
Bhardwaj, T. et al. Amyloidogenic proteins within the SARS-CoV and SARS-CoV-2 proteomes. Nat. Commun. 14, 945 (2023).
Fung, S. Y. et al. SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1. Cell Biosci. 12, 36 (2022).
Hsu, J. C.-C., Laurent-Rolle, M., Pawlak, J. B., Wilen, C. B. & Cresswell, P. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein. Proc. Natl Acad. Sci. USA 118, e2101161118 (2021).
Ricardo-Lax, I. et al. Replication and single-cycle supply of SARS-CoV-2 replicons. Science 374, 1099–1106 (2021).
Benton, D. J. et al. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion. Nature 588, 327–330 (2020).
Freitas, R. S., Crum, T. F. & Parvatiyar, Ok. SARS-CoV-2 spike antagonizes innate antiviral immunity by focusing on interferon regulatory issue 3. Entrance. Cell. Infect. Microbiol. 11, 789462 (2022).
Zhang, Q. et al. Extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) and spike (S) proteins antagonize host kind I interferon response. Entrance. Cell Infect. Microbiol. 11, 1242 (2021).
Fu, Y.-Z. et al. SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response. Cell Mol. Immunol. 18, 613–620 (2021).
Luo, L. et al. SARS-CoV-2 nucleocapsid protein part separates with G3BPs to disassemble stress granules and facilitate viral manufacturing. Sci. Bull. 66, 1194–1204 (2021).
Wang, S. et al. Focusing on liquid–liquid part separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS exercise. Nat. Cell Biol. 23, 718–732 (2021).
Gori Savellini, G., Anichini, G., Gandolfo, C. & Cusi, M. G. SARS-CoV-2 N protein targets TRIM25-mediated RIG-I activation to suppress innate immunity. Viruses 13, 1439 (2021).
Oh, S. J. & Shin, O. S. SARS-CoV-2 nucleocapsid protein targets RIG-I-like receptor pathways to inhibit the induction of interferon response. Cells 10, 530 (2021).
Chen, Ok. et al. SARS-CoV-2 nucleocapsid protein interacts with RIG-I and represses RIG-mediated IFN-β manufacturing. Viruses 13, 47 (2020).
Mu, J. et al. SARS-CoV-2 N protein antagonizes kind I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2. Cell Discov. 6, 65 (2020).
Kern, D. M. et al. Cryo-EM construction of SARS-CoV-2 ORF3a in lipid nanodiscs. Nat. Struct. Mol. Biol. 28, 573–582 (2021).
Wang, R. et al. ORF3a protein of extreme acute respiratory syndrome coronavirus 2 inhibits interferon-activated Janus kinase/sign transducer and activator of transcription signaling by way of elevating suppressor of cytokine signaling 1. Entrance. Microbiol. 12, 2871 (2021).
Qu, Y. et al. ORF3a-mediated incomplete autophagy facilitates extreme acute respiratory syndrome coronavirus-2 replication. Entrance. Cell Dev. Biol. 9, 716208 (2021).
Stewart, H. et al. The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity. iScience 26, 108080 (2023).
Cao, Z. et al. Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response. Cell Mol. Immunol. 18, 746–748 (2021).
Wu, J. et al. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO. Cell Rep. 34, 108761 (2021).
Gao, X. et al. Crystal construction of SARS-CoV-2 Orf9b in advanced with human TOM70 suggests uncommon virus–host interactions. Nat. Commun. 12, 2843 (2021).
Han, L. et al. SARS‐CoV‐2 ORF9b antagonizes kind I and III interferons by focusing on a number of elements of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways. J. Med. Virol. 93, 5376–5389 (2021).
Focosi, D. & Maggi, F. Recombination in coronaviruses, with a concentrate on SARS-CoV-2. Viruses 14, 1239 (2022).
Amoutzias, G. D. et al. The outstanding evolutionary plasticity of coronaviruses by mutation and recombination: insights for the COVID-19 pandemic and the longer term evolutionary paths of SARS-CoV-2. Viruses 14, 78 (2022).
Nikolaidis, M., Markoulatos, P., van de Peer, Y., Oliver, S. G. & Amoutzias, G. D. The neighborhood of the spike gene is a hotspot for modular intertypic homologous and nonhomologous recombination in coronavirus genomes. Mol. Biol. Evol. 39, msab292 (2022).
Müller, N. F., Kistler, Ok. E. & Bedford, T. A Bayesian strategy to deduce recombination patterns in coronaviruses. Nat. Commun. 13, 4186 (2022).
Gribble, J. et al. The coronavirus proofreading exoribonuclease mediates intensive viral recombination. PLoS Pathog. 17, e1009226 (2021). This text gives a purposeful hyperlink between the proofreading exoribonuclease and coronavirus recombination.
Turakhia, Y. et al. Pandemic-scale phylogenomics reveals the SARS-CoV-2 recombination panorama. Nature 609, 994–997 (2022).
Risk evaluation temporary: implications for the EU/EEA of the unfold of the SARS-CoV-2 Omicron XBB.1.5 sub-lineage. ECDC https://www.ecdc.europa.eu/en/publications-data/covid-19-threat-assessment-brief-implications-spread-omicron-xbb (2023).
Ogando, N. S. et al. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, fast adaptation and cytopathology. J. Gen. Virol. 101, 925–940 (2020).
Sasaki, M. et al. SARS-CoV-2 variants with mutations on the S1/S2 cleavage web site are generated in vitro throughout propagation in TMPRSS2-deficient cells. PLoS Pathog. 17, e1009233 (2021). The significance of the S1/S2 furin cleavage web site and its fast loss after in vitro virus passages is demonstrated.
Hou, Y. J. et al. SARS-CoV-2 D614G variant displays environment friendly replication ex vivo and transmission in vivo. Science 370, 1464–1468 (2020).
Han, Y., Yang, L., Lacko, L. A. & Chen, S. Human organoid fashions to check SARS-CoV-2 an infection. Nat. Strategies 19, 418–428 (2022).
Hui, Ok. P. Y. et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature 603, 715–720 (2022).
Zhou, B. et al. SARS-CoV-2 spike D614G change enhances replication and transmission. Nature 592, 122–127 (2021).
Chu, H., Chan, J. F. W. & Yuen, Ok. Y. Animal fashions in SARS-CoV-2 analysis. Nat. Strategies 19, 392–394 (2022).
Dinnon, Ok. H. et al. A mouse-adapted mannequin of SARS-CoV-2 to check COVID-19 countermeasures. Nature 586, 560–566 (2020). These authors created a mouse-adapted SARS-CoV-2, which fashions COVID-19 pathogenesis in mice and serves as an necessary mannequin system for in vivo analysis of therapeutics and vaccines.
Corbett, Ok. S. et al. Analysis of the mRNA-1273 vaccine in opposition to SARS-CoV-2 in nonhuman primates. N. Engl. J. Med. 383, 1544–1555 (2020).
Discover more from PressNewsAgency
Subscribe to get the latest posts sent to your email.